RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 33.33 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $238.000 thousand which missed the analyst consensus estimate of $419.750 thousand by 43.30 percent. This is a 453.49 percent increase over sales of $43.000 thousand the same period last year.